SCHEMBL6368244

SCHEMBL6368244

Cc1ccccc1Oc1ccccc1C(N)=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 1/20 0.62
IRAK4 Q9NWZ3 1/20 0.56
MAPT P10636 5/20 0.53
KMT2A Q03164 4/20 0.53
LMNA P02545 3/20 0.53
MEN1 O00255 3/20 0.53
NR1I2 O75469 1/20 0.53
CHRM2 P08172 1/20 0.53
CYP3A4 P08684 1/20 0.53
ADRA2A P08913 1/20 0.53
OPRK1 P41145 1/20 0.53
HTR2B P41595 1/20 0.53
SLC6A3 Q01959 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
HTT P42858 3/20 0.51
PARP1 P09874 2/20 0.45
KDM4E B2RXH2 2/20 0.45
AKR1C1 Q04828 1/20 0.44
TSHR P16473 2/20 0.44
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7693879 0.88 CTNNB1 (0.77) CTNNB1IRAK4MAPTKMT2ALMNA
SCHEMBL15902013 0.84 CTNNB1 (0.57) CTNNB1IRAK4MAPTKMT2ALMNA
SCHEMBL5175230 0.83 HTT (0.73) CTNNB1IRAK4MAPTKMT2ALMNA
SCHEMBL2867637 0.83 HTT (0.68) MAPTKMT2ALMNAMEN1CYP3A4
SCHEMBL27698525 0.83 SMN1; SMN2 (0.51) MAPTKMT2ALMNAMEN1HTT
SCHEMBL1326862 0.80 RAB9A (0.57) CTNNB1IRAK4MAPTPARP1NPC1
SCHEMBL15561845 0.80 CTNNB1 (0.53) CTNNB1IRAK4MAPTKMT2ALMNA
SCHEMBL15330096 0.80 CTNNB1 (0.49) CTNNB1IRAK4MAPTKMT2ALMNA
Hydrochloric Acid SCHEMBL23235857 0.80 F10 (0.46) CTNNB1MAPTKMT2AMEN1HTT
SCHEMBL4382994 0.80 KMT2A (0.53) KMT2ALMNAMEN1CYP3A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050256161-A1 Melanin concentrating hormone receptor antagonists AMGEN INC. 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256161-A1 Melanin concentrating hormone receptor antagonists MCHR1, MC1R, NPY1R CTNNB1 2638/4885IRAK4 4432/4885MAPT 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.